E
Nyxoah SA NYXH
$4.76 -$0.23-4.52% NASDAQ
Recommendation
Prev Close
$4.98
Volume
29,348
Avg Vol (90D)
84,978
Market Cap
$181.57M
Dividend & Yield
--
52-Week Range
$4.35 - $11.87
P/E (TTM)
--
EPS (TTM)
-$2.48
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
12/1/2025 - Zacks Investment Research
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/27/2025 - GuruFocus
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/27/2025 - Globe Newswire
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy
11/26/2025 - Stocktwits News Feed
Nyxoah (NYXH) Gains Enhanced Reimbursement Boost from CMS for 2026
11/26/2025 - GuruFocus
Nyxoah receives Medicare reimbursement increases for Genio
11/26/2025 - The Fly
Nyxoah (NYXH) Sees Significant Medicare Reimbursement Boost for 2026
11/26/2025 - GuruFocus
Nyxoah's Genio therapy gets significant 2026 Medicare reimbursement increases under final CMS rule
11/26/2025 - SeekingAlpha.com: All News
Nyxoah's Genio therapy gets significant 2026 Medicare reimbursement increases under final CMS rule
11/26/2025 - Seeking Alpha - Healthcare
Nyxoah's Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
11/26/2025 - Globe Newswire
Nyxoah SA (NYXH) Q3 2025 Earnings Call Highlights: Strong US Launch and Strategic Expansion ...
11/24/2025 - GuruFocus
Q3 2025 Nyxoah SA Earnings Call Transcript
11/23/2025 - GuruFocus
Cantor Fitzgerald Raises Earnings Estimates for Nyxoah
11/22/2025 - MarketBeat
Information on the total number of voting rights and shares
11/20/2025 - Globe Newswire
Nyxoah SA (NYXH, $4.76) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 17, 2025
11/18/2025 - Tickeron - Stocks
Nyxoah's Earnings Call: Optimism Amidst Challenges
11/16/2025 - TipRanks Financial Blog
Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results, Misses Expectations By $0.13 EPS
11/14/2025 - MarketBeat
Nyxoah (NYXH) Price Target Lowered by Piper Sandler NYXH Stock News
11/14/2025 - GuruFocus
Stifel Nicolaus Reaffirms Their Buy Rating on Nyxoah (NYXH)
11/14/2025 - TipRanks Financial Blog
Surprising Analyst 12-Month Target For BMED
11/14/2025 - ETF Channel
Nyxoah SA (NYXH, $5.31) price exceeded its 50-day Moving Average on November 13, 2025
11/14/2025 - Tickeron - Stocks
Piper Sandler Sticks to Its Buy Rating for Nyxoah (NYXH)
11/14/2025 - TipRanks Financial Blog
Nyxoah price target lowered to $9 from $12 at Piper Sandler
11/14/2025 - TipRanks Financial Blog
Nyxoah price target lowered by $3 at Piper Sandler, here's why
11/14/2025 - The Fly
Nyxoah SA (NYXH) Q3 2025 Earnings Call Transcript
11/14/2025 - SeekingAlpha
Income Statement
Total Revenue (TTM)
$6.29M
EBITDA (TTM)
-$91.12M
EBIT (TTM)
-$92.26M
Net Income (TTM)
-$92.79M
Balance Sheet
Total Assets (Q)
$109.82M
Total Debt (Q)
$24.83M
Total Liabilities (Q)
$50.04M
Book Value Per Share (Q)
$1.59
Cash Flow
Cash from Operations (TTM)
-$75.43M
Cash from Investing (TTM)
$33.03M
Cash from Financing (TTM)
$23.26M
Net Change in Cash (TTM)
-$20.02M
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
1.17
7-Day Total Return
4.51%
30-Day Total Return
-18.99%
60-Day Total Return
-18.58%
90-Day Total Return
-37.27%
Year to Date Total Return
-47.40%
1-Year Total Return
-40.56%
2-Year Total Return
-2.96%
3-Year Total Return
-4.52%
5-Year Total Return
--
52-week Low
Sep 26, 2025 - $4.35
52-week High
Mar 25, 2025 - $11.87
Valuation
Market Cap
$181.57M - Micro Cap
Enterprise Value
$180.04M
Price/Sales (TTM)
29.64
Price/Book (Q)
3.13
Dividends and Shares
Shares Outstanding
37.45
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.nyxoah.com
Phone Number
32 1 022 23 55
Address
Rue Edouard Belin 12
Mont-Saint-Guibert, 1435
Country
Belgium
Year Founded
2009
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked... more
NASDAQ 12/02/2025 10:54AM Eastern Quotes delayed